The role of hypervirulent Staphylococcus aureus infections in the development of deep vein thrombosis

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages 302-308

  Martin, Eric ^a   Cevik, Cihan ^b   Nugent, Kenneth ^a  

^a TEXAS TECH UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

anticoagulation; coagulation; deep vein thrombosis; Staphylococcus aureus

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; ANTITHROMBIN III; BACTERIAL PROTEIN; BACTERIAL TOXIN; BLOOD CLOTTING FACTOR; CLUMPING FACTOR A; CLUMPING FACTOR B; CYTOKINE; FIBRONECTIN; FIBRONECTIN A; FIBRONECTIN B; HEPARIN; HISTAMINE; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; MICROBIAL SURFACE COMPONENTS RECOGNIZING ADHESIVE MATRIX MOLECULE; PANTON VALENTINE LEUKOCIDIN; REACTIVE OXYGEN METABOLITE; STAPHYLOCOCCUS PROTEIN A; THROMBOMODULIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG; VANCOMYCIN; VASCULAR CELL ADHESION MOLECULE 1;

BACTEREMIA; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; BLOOD CLOTTING; CELLULITIS; COMMUNITY ACQUIRED PNEUMONIA; CYTOLYSIS; DEEP VEIN THROMBOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FIBRINOLYSIS; HEMATOGENOUS OSTEOMYELITIS; HUMAN; LEUKOCYTE; LOWER EXTREMITY DEEP VEIN THROMBOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROCIRCULATION; MICROTHROMBUS; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SEPSIS; SEPTIC SHOCK; SPLANCHNIC BLOOD FLOW; SPLANCHNIC VEIN THROMBOSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SYSTEMATIC REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOGENESIS; VASCULAR ENDOTHELIUM; VEIN THROMBOSIS;

CAUSALITY; COMORBIDITY; CROSS INFECTION; HUMANS; INCIDENCE; STAPHYLOCOCCAL INFECTIONS; VENOUS THROMBOSIS;

EID: 84865267940     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.06.013     Document Type: Review

References (100)

1. S. Margetic Inflammation and haemostasis Biochem Med (Zagreb) 22 2012 49 62
2. M. Levi The coagulant response in sepsis and inflammation Hamostaseologie 30 2010 10 16
3. E. Martin, W. Frandah, R. Raj, and K. Nugent A young adult with a fulminant Staphylococcus aureus infection and multiple thrombi Chest Dis Rep 1 2011 E16 10.4081/cdr.2011.e16
4. M. Levi, T. van der Poll, and M. Schultz Systemic versus localized coagulation activation contributing to organ failure in critically ill patients Semin Immunopathol 34 2012 167 179
5. J.H. Smalberg, M. Kruip, H. Janssen, D.C. Rijken, F.W. Leebeek, and M.P. de Maat Arteriosclerosis, thrombosis, and vascular biology Arterioscler Thromb Vasc Biol 35 2011 485 493
6. M. Levi The Coagulant Response in Sepsis Clin Chest Med 29 2008 627 642
7. R. Bach, Y. Nemerson, and W. Konigsberg Purification and characterization of bovine tissue factor J Biol Chem 256 1981 8324 8331
8. G.J. Broze Jr., J.E. Leykam, B.D. Schwartz, and J.P. Miletich Purification of human brain tissue factor J Biol Chem 260 1985 10917 10920
9. T.A. Drake, J.H. Morrissey, and T.S. Edgington Selective cellular expression of tissue factor in human tissues: Implications for disorders of hemostasis and thrombosis Am J Pathol 134 1989 1087 1097
10. J.M. Patti, B.L. Allen, M.J. McGavin, and M. Höök MSCRAMM-mediated adherence of microorganisms to host tissues Annu Rev Microbiol 48 1994 585 617
11. J.M. Rivas, P. Speziale, J.M. Patti, and M. Höök MSCRAMM-targeted vaccines and immunotherapy for staphylococcal infection Curr Opin Drug Discov Dev 7 2004 223 227
12. T.J. Foster, and M. Höök Surface protein adhesins of Staphylococcus aureus Trends Microbiol 6 1998 484 488
13. P. Speziale, G. Pietrocola, S. Rindi, M. Provenzano, G. Provenza, and A. Di Poto Structural and functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the host Future Microbiol 4 2009 1337 1352
14. J. Hartleib, N. Köhler, R.B. Dickinson, G.S. Chhatwal, J.J. Sixma, and O.M. Hartford Protein A is the von Willebrand factor binding protein on Staphylococcus aureus Blood 96 2000 2149 2156
15. T. Nguyen, B. Ghebrehiwet, and E.I. Peerschke Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets Infect Immun 68 2000 2061 2068
16. J.R. Fitzgerald, A. Loughman, F. Keane, M. Brennan, M. Knobel, and J. Higgins Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor Mol Microbiol 59 2006 212 230
17. E.I. Peerschke, K.B. Reid, and B. Ghebrehiwet Identification of a novel 33-kDa C1q-binding site on human blood platelets J Immunol 152 1994 5896 5901
18. W.X. Guo, B. Ghebrehiwet, B. Weksler, K. Schweitzer, and E.I. Peerschke Up-regulation of endothelial cell binding proteins/receptors for complement component C1q by inflammatory cytokines J Lab Clin Med 133 1999 541 550
19. P. Pawar, P.K. Shin, S.A. Mousa, J.M. Ross, and K. Konstantopoulos Fluid shear regulates the kinetics and receptor specificity of Staphylococcus aureus binding to activated platelets J Immunol 173 2004 1258 1265
20. R. Heying, J. van de Gevel, Y.A. Que, P. Moreillon, and H. Beekhuizen Fibronectin-binding proteins and clumping factor A in Staphylococcus aureus experimental endocarditis: FnBPA is sufficient to activate human endothelial cells Thromb Haemost 97 2007 617 626
21. L. O'Brien, S.W. Kerrigan, G. Kaw, M. Hogan, J. Penadés, and D. Litt Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A Mol Microbiol 44 2002 1033 1044
22. S.W. Kerrigan, N. Clarke, A. Loughman, G. Meade, T.J. Foster, and D. Cox Molecular basis for Staphylococcus aureus-mediated platelet aggregate formation under arterial shear in vitro Arterioscler Thromb Vasc Biol 28 2008 335 340
23. N. Palmqvist, J.M. Patti, A. Tarkowski, and E. Josefsson Expression of staphylococcal clumping factor A impedes macrophage phagocytosis Microbes Infect 6 2004 188 195
24. J. Higgins, A. Loughman, K.P. van Kessel, J.A. van Strijp, and T.J. Foster Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes FEMS Microbiol Lett 258 2006 290 296
25. P.S. Hair, M.D. Ward, O.J. Semmes, T.J. Foster, and K.M. Cunnion Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b J Infect Dis 198 2008 125 133
26. E. Josefsson, J. Higgins, T.J. Foster, and A. Tarkowski Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence PLoS One 3 2008 e2206
27. L.M. O'Brien, E.J. Walsh, R.C. Massey, S.J. Peacock, and T.J. Foster Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization Cell Microbiol 4 2002 759 770
28. E.J. Walsh, L.M. O'Brien, X. Liang, M. Hook, and T.J. Foster Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10 J Biol Chem 279 2004 50691 50699
29. B. Shenkman, E. Rubinstein, A.L. Cheung, G.E. Brill, R. Dardik, and I. Tamarin Adherence properties of Staphylococcus aureus under static and flow conditions: roles of agr and sar loci, platelets, and plasma ligands Infect Immun 69 2001 4473 4478
30. B. Shenkman, D. Varon, I. Tamarin, R. Dardik, M. Peisachov, and N. Savion Role of agr (RNAIII) in Staphylococcus aureus adherence to fibrinogen, fibronectin, platelets and endothelial cells under static and flow conditions J Med Microbiol 51 2002 747 754
31. M. Li, B.A. Diep, A.E. Villaruz, K.R. Braughton, X. Jiang, and F.R. DeLeo Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus Proc Natl Acad Sci U S A 106 2009 5883 5888
32. U. Abildgaard Binding of thrombin to antithrombin III Scand J Clin Lab Invest 24 1969 23 27
33. H.P. Schuster, B. Eisele, and H.O. Keinecke S-antithrombin III study: antithrombin III in patients with severe sepsis Intensive Care Med Suppl. 1 1998 76
34. B. Eisele, M. Lamy, L.G. Thijs, H.O. Keinecke, H.P. Schuster, and F.R. Matthias Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis Intensive Care Med 24 1998 663 672
35. F. Fourrier, C. Chopin, J.J. Huart, I. Runge, C. Caron, and J. Goudemand Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation Chest 104 1993 882 888
36. D. Inthorn, J.N. Hoffmann, W.H. Hartl, D. Mühlbayer, and M. Jochum Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis Shock 10 1998 90 96
37. W.C. Aird Vascular bed-specific hemostasis: role of endothelium in the sepsis pathogenesis Crit Care Med 29 7 Suppl. Jul 2001 S28 S34
38. H. Ishii, H.H. Salem, C.E. Bell, E.A. Laposata, and P.W. Majerus Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain Blood 67 1986 362 365
39. D.J. Stearns-Kurosawa, S. Kurosawa, J.S. Mollica, G.L. Ferrell, and C.T. Esmon The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex Proc Natl Acad Sci U S A 93 1996 10212 10216
40. M.S. Bajaj, M.N. Kuppuswamy, H. Saito, S.G. Spitzer, and S.P. Bajaj Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis Proc Natl Acad Sci U S A 87 1990 8869 8873
41. W.C. Aird Vascular bed-specific thrombosis J Thromb Haemost 5 Suppl. 1 2007 283 291
42. M.S. Bajaj, and S.P. Bajaj Tissue factor pathway inhibitor: potential therapeutic applications Thromb Haemost 78 1997 471 477
43. R.W. Werling, L.R. Zacharski, W. Kisiel, S.P. Bajaj, V.A. Memoli, and S.M. Rousseau Distribution of tissue factor pathway inhibitor in normal and malignant human tissues Thromb Haemost 69 1993 366 369
44. O. Nordfang, S.E. Bjørn, S. Valentin, L.S. Nielsen, P. Wildgoose, and T.C. Beck The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity Biochemistry 30 1991 10371 10376
45. R. Wesselschmidt, K. Likert, T. Girard, T.C. Wun, and G.J. Broze Jr. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa Blood 79 1992 2004 2010
46. R. Hoffman, E.J. Benz Jr., S.J. Shattil, B. Furei, L.E. Silberstein, P. McGlave, H.E. Heslop, and J. Anastasi Hematology: Basic Principles and Practice 5th ed. 2009 Churchill Livingstone Philadelphia
47. M. Levi, T. van der Poll, and H.R. Büller Bidirectional relation between inflammation and coagulation Circulation 109 2004 2698 2704
48. P.P. Nawroth, and D.M. Stern Modulation of endothelial cell hemostatic properties by tumor necrosis factor J Exp Med 163 1986 740 745
49. S.N. Faust, M. Levin, O.B. Harrison, R.D. Goldin, M.S. Lockhart, and S. Kondaveeti Dysfunction of endothelial protein C activation in severe meningococcal sepsis N Engl J Med 345 2001 408 416
50. F.B. Taylor Jr., D.J. Stearns-Kurosawa, S. Kurosawa, G. Ferrell, A.C. Chang, and Z. Laszik The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis Blood 95 2000 1680 1686
51. M. Kishiwada, T. Hayashi, H. Yuasa, K. Fujii, J. Nishioka, and N. Akita Regulatory mechanisms of C4b-binding protein (C4BP) alpha and beta expression in rat hepatocytes by lipopolysaccharide and interleukin-6 J Thromb Haemost 6 2008 1858 1867
52. A.P. Wheeler, and G.R. Bernard Treating patients with severe sepsis N Engl J Med 340 1999 207 214
53. M. Levi, E. de Jonge, and T. van der Poll Sepsis and disseminated intravascular coagulation J Thromb Thrombolysis 16 2003 43 47
54. R. Chakraverty, S. Davidson, K. Peggs, P. Stross, C. Garrard, and T.J. Littlewood The incidence and cause of coagulopathies in an intensive care population Br J Haematol 93 1996 460 463
55. J.B. MacLeod, M. Lynn, M.G. McKenney, S.M. Cohn, and M. Murtha Early coagulopathy predicts mortality in trauma J Trauma 55 2003 39 44
56. A.F. Shorr, S.J. Thomas, S.A. Alkins, T.M. Fitzpatrick, and G.S. Ling D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients Chest 121 2002 1262 1268
57. J.T. Owings, R.C. Gosselin, J.T. Anderson, F.D. Battistella, M. Bagley, and E.C. Larkin Practical utility of the D-dimer assay for excluding thromboembolism in severely injured trauma patients J Trauma 51 2001 425 429
58. G.R. Bernard, J.L. Vincent, P.F. Laterre, S.P. LaRosa, J.F. Dhainaut, and A. Lopez-Rodriguez Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 2001 699 709
59. S. Gando, S. Nanzaki, S. Sasaki, and O. Kemmotsu Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation Thromb Haemost 79 1998 1111 1115
60. K. Yamamoto, V. de Waard, C. Fearns, and D.J. Loskutoff Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo Blood 92 1998 2791 2801
61. B. Osterud, M.S. Bajaj, and S.P. Bajaj Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. On behalf of the Subcommittee on Tissue Factor Pathway Inhibitor (TFPI) of the Scientific and Standardization Committee of the ISTH Thromb Haemost 73 1995 873 875
62. J.C. Paterson, and J. McLachlin Precipitating factors in venous thrombosis Surg Gynecol Obstet 98 1954 96 102
63. J.D. Hamer, P.C. Malone, and I.A. Silver The PO2 in venous valve pockets: its possible bearing on thrombogenesis Br J Surg 68 1981 166 170
64. F. Lurie, R.L. Kistner, B. Eklof, and D. Kessler Mechanism of venous valve closure and role of the valve in circulation: a new concept J Vasc Surg 38 2003 955 961
65. E.E. Eriksson, E. Karlof, K. Lundmark, P. Rotzius, U. Hedin, and X. Xie Powerful inflammatory properties of large vein endothelium in vivo Arterioscler Thromb Vasc Biol 25 2005 723 728
66. J.S. Pober, and R.S. Cotran The role of endothelial cells in inflammation Transplantation 50 1990 537 544
67. B. König, G. Prévost, Y. Piémont, and W. König Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes J Infect Dis 171 1995 607 613
68. L.A. Boxer, and J.E. Smolen Neutrophil granule constituents and their release in health and disease Hematol Oncol Clin North Am 2 1988 101 134
69. J.S. Pober, and W.C. Sessa Evolving functions of endothelial cells in inflammation Nat Rev Immunol 7 2007 803 815
70. R.E. Jordan, J. Kilpatrick, and R.M. Nelson Heparin promotes the inactivation of antithrombin by neutrophil elastase Science 237 1987 777 779
71. M. Levi, and H. Ten Cate Disseminated intravascular coagulation N Engl J Med 341 1999 586 592
72. M.G. Vervloet, L.G. Thijs, and C.E. Hack Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock Semin Thromb Hemost 24 1998 33 44
73. Y. López-Aguirre, and J.A. Páramo Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis Thromb Res 94 1999 95 101
74. F.B. Taylor Jr., T.E. Emerson Jr., R. Jordan, A.K. Chang, and K.E. Blick Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons Circ Shock 26 1988 227 235
75. S. Takano, S. Kimura, S. Ohdama, and N. Aoki Plasma thrombomodulin in health and diseases Blood 76 1990 2024 2029
76. B.A. Steppich, I. Seitz, G. Busch, A. Stein, and I. Ott Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases Thromb Haemost 100 2008 1068 1075
77. H.Z. Movat, and S. Wasi Severe microvascular injury induced by lysosomal releasates of human polymorphonuclear leukocytes. Increase in vasopermeability, hemorrhage, and microthrombosis due to degradation of subendothelial and perivascular matrices Am J Pathol 121 1985 404 417
78. M.S. Dahn, M.P. Lange, R.F. Wilson, L.A. Jacobs, and R.A. Mitchell Hepatic blood flow and splanchnic oxygen consumption measurements in clinical sepsis Surgery 107 1990 295 301
79. Y. Bayraktar, and O. Harmanci Etiology and consequences of thrombosis in abdominal vessels World J Gastroenterol 12 2006 1165 1174
80. M.S. Dahn, P. Lange, K. Lobdell, B. Hans, L.A. Jacobs, and R.A. Mitchell Splanchnic and total body oxygen consumption differences in septic and injured patients Surgery 101 1987 69 80
81. Y.M. Fong, M.A. Marano, L.L. Moldawer, H. Wei, S.E. Calvano, and J.S. Kenney The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans J Clin Invest 85 1990 1896 1904
82. E. Ruokonen, J. Takala, A. Kari, H. Saxén, J. Mertsola, and E.J. Hansen Regional blood flow and oxygen transport in septic shock Crit Care Med 21 1993 1296 1303
83. C.P. Steffes, M.S. Dahn, and M.P. Lange Oxygen transport-dependent splanchnic metabolism in the sepsis syndrome Arch Surg 129 1994 46 52
84. D.W. Wilmore, C.W. Goodwin, L.H. Aulick, M.C. Powanda, A.D. Mason Jr., and B.A. Pruitt Jr. Effect of injury and infection on visceral metabolism and circulation Ann Surg 192 1980 491 504
85. M.M. Parker, J.H. Shelhamer, S.L. Bacharach, M.V. Green, C. Natanson, and T.M. Frederick Profound but reversible myocardial depression in patients with septic shock Ann Intern Med 100 1984 483 490
86. J. Takala Determinants of splanchnic blood flow Br J Anaesth 77 1996 50 58
87. O.A. Antonova, S.A. Loktionova, Y.A. Romanov, O.N. Shustova, M.V. Khachikian, and A.V. Mazurov Activation and damage of endothelial cells upon hypoxia/reoxygenation. Effect of extracellular pH Biochemistry (Mosc) 74 2009 605 612
88. P.R. Póvoa, A.H. Carneiro, O.S. Ribeiro, A.C. Pereira Portuguese Community-Acquired Sepsis Study Group Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study) Crit Care Med 37 2009 410 416
89. N. Sennoun, C. Montemont, S. Gibot, P. Lacolley, and B. Levy Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock Crit Care Med 35 2007 1736 1740
90. S. Bouchoucha, F. Benghachame, M. Trifa, W. Saied, W. Douira, and M.N. Nessib Deep venous thrombosis associated with acute hematogenous osteomyelitis in children Orthop Traumatol Surg Res 96 2010 890 893
91. S.T. Hollmig, L.A. Copley, R.H. Browne, L.M. Grande, and P.L. Wilson Deep venous thrombosis associated with osteomyelitis in children J Bone Joint Surg Am 89 2007 1517 1523
92. B.E. Gonzalez, J. Teruya, D.H. Mahoney Jr., K.G. Hulten, R. Edwards, and L.B. Lamberth Venous thrombosis associated with staphylococcal osteomyelitis in children Pediatrics 117 2006 1673 1679
93. C. Nourse, M. Starr, and W. Munckhof Community-acquired methicillin-resistant Staphylococcus aureus causes severe disseminated infection and deep venous thrombosis in children: literature review and recommendations for management J Paediatr Child Health 43 2007 656 661
94. S.E. Crary, G.R. Buchanan, C.E. Drake, and J.M. Journaycake Venous thrombosis and thromboembolism in children with osteomyelitis J Pediatr 149 2006 537 541
95. K.Z. Vardakas, D.K. Matthaiou, and M.E. Falagas Comparison of community-acquired pneumonia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus producing the Panton-Valentine keukocidin Int J Tuberc Lung Dis 13 2009 1476 1485
96. E. Martin, J. Colmer-Hamood, W. Frandah, R. Raj, and K. Nugent Clinical and microbiological characteristics of community acquired methicillin-resistant Staphylococcus aureus pneumonia Chest Dis Rep 2012 e7 10.4081/cdr.2012.e7
97. C. Liu, A. Bayer, S.E. Cosgrove, R.S. Daum, S.K. Fridkin, and R.J. Gorwitz Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary Clin Infect Dis 52 2011 285 292
98. B. Spellberg, and R. Daum Development of a vaccine against Staphylococcus aureus Semin Immunopathol 34 2012 335 348
99. S.W. Kerrigan, and D. Cox Platelet-bacterial interactions Cell Mol Life Sci 67 2010 513 523
100. R. Zarychanski, S. Doucette, D. Fergusson, D. Roberts, D.S. Houston, S. Sharma, H. Gulati, and A. Kumar Early intravenous unfractionated heparin and mortality in septic shock Crit Care Med 36 2008 2973 2979